← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › VACCINES › VIRAL VACCINES › Covid-19 vaccines
covid-19, RNA-based vaccine
J07BN01
Forms & Strengths
- 0.5ml single-dose vial
- multiple-dose vial (5 doses per vial)
Adult Dosing
- 2 doses, 21 days apart
- booster dose, 6 months after primary series
Pediatric Dosing
- 12-15 years: 2 doses, 21 days apart
- 16-17 years: same as adult dosing
- children under 12 years: not approved
Indications
- prevention of COVID-19 caused by SARS-CoV-2
- active immunization in individuals 12 years and older
Mechanism of Action
- induces immune response against SARS-CoV-2 spike protein
- stimulates production of neutralizing antibodies
Contraindications
- hypersensitivity to any vaccine component
- anaphylaxis to previous mRNA vaccine
Adverse Reactions
- pain at injection site
- fatigue
- headache
- myalgia
- chills
- fever
- lymphadenopathy
- anaphylaxis (rare)
Drug Interactions
- immunosuppressants may reduce vaccine efficacy
- co-administration with other vaccines: not evaluated
- avoid concomitant use with immunoglobulins
Curated Content: Needs Vetting Before Put to Clinical Use